Canopy Growth Shares Drop as Canadian Adult-Use Cannabis Drags Total Revenue in 2Q

Dow Jones11-08
 

By Adriano Marchese

 

Canopy Growth shares fell as a decline in Canadian adult-use cannabis weighed heavily on the company's revenue in the second fiscal quarter, days after an industry-wide collapse in cannabis stocks.

Shares traded 7.8% lower at 5.81 Canadian dollars ($4.19).

The Smiths Falls, Ontario-based cannabis company reported a 9% decline in total revenue to C$63 million, missing consensus expectations of C$64.2 million, according to FactSet.

Canopy saw a significant decline in Canadian adult-use cannabis, where revenue fell 24% to C$18.4 million. This offset the 16% gain from Canadian medical cannabis which reached C$18.7 million, and international markets cannabis which rose 12% to C$10.1 million.

The decline follows recent industry-wide pullback in cannabis stocks, in which Canopy wasn't spared, after initiatives to legalize recreational marijuana in Florida, North Dakota and South Dakota failed to receive enough votes.

 

Write to Adriano Marchese at adriano.marchese@wsj.com

 

(END) Dow Jones Newswires

November 08, 2024 10:50 ET (15:50 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment